EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes is a research paper published in American Journal Of Pathology (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Defense
Grant: CA180361
National Institutes of Health
Grant: CA102325
National Institutes of Health
Grant: CA219541
National Institutes of Health
Grant: CA226281
NCI NIH HHS
Grant: R01 CA226281
NCI NIH HHS
Grant: R01 CA219541
NCI NIH HHS
Grant: R01 CA102325
National Institutes of Health
Grant: 5R01CA226281-02
The Long Noncoding RNA MALAT1 in Liver Cancer
National Institutes of Health
Grant: 2R01CA219541-07A1
Epigenetic Mechanisms of Biliary Epithelial Neoplasia
National Institutes of Health
Grant: 5R01CA102325-04
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma
FWCI
4.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals